Skip to main content

Avalyn Pharma Inc 10-Q for FY2026 Q1

Avalyn Pharma Inc. (AVLN)

10-Q 2026-06-03 For: 2026-03-31
View Original
Added on June 03, 2026

About this 10-Q

Avalyn Pharma Inc filed this 10-Q on June 3, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$26.87M
compared with a net loss of $17.5M a year earlier
Diluted EPS
-$21.83
compared with -$63.24 a year earlier